◆英語タイトル:Luxembourg Institute of Health - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9398
◆発行会社(調査会社):
GlobalData
◆発行日:2018年11月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ルクセンブルク
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Luxembourg Institute of Health (LIH), formerly Centre de Recherche Public de la Sante is a biomedical research organisation that offers pre-clinical and clinical research in the areas of biomedicine and healthcare. The organization offers research under various departments such as infection and immunity, oncology, and population health. It also offers research support services including methodology and statistics, research knowledge transfer office, and doctoral training services. LIH’s business activities include generation of new disease mechanisms, diagnostics and treatments of human diseases; improve the understanding of health determinants and also the financial structures of health care. The organization also supports thematic research departments. It provides training and workshops for early-stage researchers. LIH is headquartered in Strassen, Luxembourg.
Luxembourg Institute of Health – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Luxembourg Institute of Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Luxembourg Institute of Health, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Luxembourg Institute of Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Luxembourg Institute of Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Luxembourg Institute of Health, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Luxembourg Institute of Health, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Complix Raises US$15.5 Million In Series B Financing 10
Partnerships 12
WaferGen Biosystems Enters into Agreement with Luxembourg Institute of Health 12
University of Twente, Luxembourg Institute of Health and University of York Enter into Research Collaboration 13
iQur Enters into Co-Development Agreement with Six Consortium 14
Licensing Agreements 15
Advanced Biological Labs Enters Into Licensing Agreement With CRP-Sante For Comet Software 15
Luxembourg Institute of Health – Key Competitors 16
Luxembourg Institute of Health – Key Employees 17
Luxembourg Institute of Health – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Strategy And Business Planning 19
May 02, 2017: Treating cancer with viruses – Inauguration of a new binational research unit 19
Mar 09, 2017: The Cancer Foundation supports a project on cancer virotherapy of a newly created research group at LIH and DKFZ 20
Government and Public Interest 21
Apr 17, 2018: Luxembourg Institute of Health: Efficient control of leukaemia with treatment by dual immune-checkpoint blockade 21
May 17, 2017: Launch of the SYS-T-Act study: towards a personalised treatment of allergies 22
Apr 19, 2017: Master detox molecule boosts immune defence 23
Feb 28, 2017: FNR and LIH support Luxembourg research project on rare disease 24
Feb 01, 2017: LIH contributes to an important worldwide study on blood pressure with national data 25
Jan 16, 2017: Erasmus+ Award for a multinational project coordinated by LIH 26
Product News 27
Jan 10, 2017: Advancing brain tumour research with preclinical MRI studies 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28
List of Tables
Luxembourg Institute of Health, Pharmaceuticals & Healthcare, Key Facts 2
Luxembourg Institute of Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Luxembourg Institute of Health, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Luxembourg Institute of Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Luxembourg Institute of Health, Deals By Therapy Area, 2012 to YTD 2018 8
Luxembourg Institute of Health, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Complix Raises US$15.5 Million In Series B Financing 10
WaferGen Biosystems Enters into Agreement with Luxembourg Institute of Health 12
University of Twente, Luxembourg Institute of Health and University of York Enter into Research Collaboration 13
iQur Enters into Co-Development Agreement with Six Consortium 14
Advanced Biological Labs Enters Into Licensing Agreement With CRP-Sante For Comet Software 15
Luxembourg Institute of Health, Key Competitors 16
Luxembourg Institute of Health, Key Employees 17
Luxembourg Institute of Health, Other Locations 18
List of Figures
Luxembourg Institute of Health, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Luxembourg Institute of Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Luxembourg Institute of Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Luxembourg Institute of Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Luxembourg Institute of Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Luxembourg Institute of Health, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Luxembourg Institute of Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Luxembourg Institute of Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8